🔗 Permalink

Inventor profile of:

Sonia Gervais

City:

Laval

Country:

Canada

Published Applications:

Last publication date:

2021-09-30

Top Assignees for applications by Sonia Gervais

The entities that hold a legal rights for patent applications filed by inventor Gervais Sonia:

PALADIN LABS EUROPE LIMITED 11 Dublin, Ireland
PALADIN LABS (BARBADOS) INC. 7 Hastings, Christ Church, Barbados
Paladin Labs Inc. 6 Montreal (Quebec), Canada
Paladin Labs Inc. 5 Montreal, Canada
Paladin Labs (Barbados) Inc. 5 Hastings, Barbados
Angelini Pharma Inc. 3 Gaithersburg, MD United States
Labopharm, Inc. 3 Quebec, Canada
Labopharm Europe Limited 3 Dublin, Ireland
Labopharm (Barbados) Limited 2 Hastings, Christ Church, Barbados
Altus Formulation Inc. 2 Mirabel, Canada
PALADIN LABS INC. 2 Montreal, QC Canada
Labopharm (Barbados) Limited 1 St. Michael, Barbados
Angelini Labopharm, LLC 1 Princeton, NJ United States

Recent patent applications by Gervais Sonia

Sonia Gervais from Laval, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-09-30

US20210299259A1

Human necessities

Starch-based release modifying excipients and pharmaceutical compositions derived therefrom

#2 | 2020-09-24

US20200297857A1

Human necessities

Starch-based release modifying excipients and pharmaceutical compositions derived therefrom

#3 | 2018-07-05

US20180185292A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#4 | 2018-07-05

US20180185289A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#5 | 2016-12-22

US20160367483A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#6 | 2016-12-15

US20160361262A1

Human necessities

SUSTAINED DRUG RELEASE COMPOSITION

#7 | 2016-10-27

US20160310432A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#8 | 2015-10-29

US20150306041A1

Human necessities

SUSTAINED DRUG RELEASE COMPOSITION

#9 | 2015-10-01

US20150272890A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#10 | 2015-10-01

US20150272888A1

Human necessities

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

#11 | 2014-10-02

US20140294955A1

Human necessities

Misuse preventative, controlled release formulation

#12 | 2014-10-02

US20140294954A1

Human necessities

Misuse preventative, controlled release formulation

#13 | 2014-09-04

US20140248346A1

Human necessities

Misuse preventative, controlled release formulation

#14 | 2014-07-10

US20140193494A1

Human necessities

Misuse preventative, controlled release formulation

#15 | 2014-01-02

US20140004191A1

Human necessities

Misuse preventative, controlled release formulation

#16 | 2013-12-26

US20130344142A1

Human necessities

Misuse preventative, controlled release formulation

#17 | 2011-02-10

US20110033537A1

Human necessities

Sustained drug release composition

#18 | 2011-02-03

US20110027370A1

Human necessities

Sustained drug release composition

#19 | 2011-01-27

US20110021535A1

Human necessities

Trazodone composition for once a day administration

#20 | 2011-01-20

US20110015205A1

Human necessities

Trazodone Composition for Once a Day Administration

#21 | 2010-09-23

US20100239662A1

Human necessities

Misuse preventative, controlled release formulation

#22 | 2010-06-17

US20100151022A9

Human necessities

Controlled-release compositions

#23 | 2009-07-09

US20090175937A1

Human necessities

Misuse preventative, controlled release formulation

#24 | 2009-05-21

US20090130183A1

Human necessities

Bilayer composition for the sustained release of acetaminophen and tramadol

#25 | 2009-02-19

US20090047345A9

Human necessities

Sustained-release tramadol formulations with 24-hour efficacy

#26 | 2007-06-07

US20070128275A1

Human necessities

Trazodone composition for once a day administration

#27 | 2007-06-07

US20070128269A1

Human necessities

Sustained drug release compositions

#28 | 2007-01-04

US20070003618A1

Human necessities

Sustained-release tramadol formulations with 24-hour efficacy

#29 | 2006-10-26

US20060240107A1

Human necessities

Controlled-release compositions

#30 | 2006-08-03

US20060172006A1

Human necessities

Sustained-release tramadol formulations with 24-hour clinical efficacy

InventorID:

586087 ⎘